Related Experiment Video
Updated: Aug 23, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Pulmonary fungal infections in immunocompromised children
1Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.
Abstract:
Pulmonary mycoses are increasingly encountered in children with underlying diseases associated with immunosuppression, including children with cancer or HIV infection. Knowledge of the epidemiology and pathogenesis of pulmonary mycoses can be applied to prevent infection in many cases and to promptly diagnose infections that do occur. Treatment is usually successful if initiated early, although pulmonary aspergillosis and zygomycosis are portentous ailments unless surgical resection or prompt immunologic recovery ensue.
Insights
Pulmonary mycoses are rising in immunocompromised children, particularly those with cancer or HIV. Early diagnosis and treatment are key for successful outcomes, though some fungal infections remain serious.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Mycology
Background:
- Pulmonary mycoses are a growing concern in pediatric patients with compromised immune systems.
- Conditions like cancer and HIV infection increase susceptibility to these fungal lung infections.
Purpose of the Study:
- To highlight the increasing incidence of pulmonary mycoses in immunocompromised children.
- To emphasize the importance of understanding epidemiology and pathogenesis for prevention and diagnosis.
- To discuss treatment strategies and challenges in managing these infections.
Main Methods:
- Review of current literature on pediatric pulmonary mycoses.
- Analysis of epidemiological trends in at-risk pediatric populations.
- Discussion of diagnostic approaches and treatment outcomes.
Main Results:
- Pulmonary fungal infections are frequently observed in children with cancer and HIV.
- Knowledge of disease patterns aids in infection prevention and timely diagnosis.
- Early intervention improves treatment success rates.
Conclusions:
- Prompt diagnosis and treatment are crucial for managing pulmonary mycoses in immunocompromised children.
- Pulmonary aspergillosis and zygomycosis pose significant risks and require aggressive management, including potential surgical intervention or immune support.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Pneumonia I: Introduction

